2021 Global Biopharmaceutical Investment and Financing Report

At the beginning of 2022, VBInsight initiated the statistical analysis of investment and financing data in the biopharmaceutical sector, aiming to promptly provide industry professionals with the 2021 Biopharmaceutical Investment and Financing Report.

By mining and cleaning nearly 30,000 investment and financing records from the VCBeat database, we analyze the sub-sectors of biomedical industry funding in 2021, using real-world data to substantiate the evolving development trends of the biomedical sector since 2013.

This report will be premiered online via live stream. You are welcome to join the live broadcast on time for real-time interaction with us. Please see the image below for specific event details.

The VBInsight database is continuously undergoing backend updates and errata corrections. If you notice discrepancies between certain data in this report and previous versions, this reflects our ongoing efforts in data collection and curation.

Thank you for your continued support and understanding of VCBeat New Medicine/VCBeat Orange Database. We look forward to continuing our journey with you in the future.